NO20044098L - Nye forbindelser - Google Patents

Nye forbindelser

Info

Publication number
NO20044098L
NO20044098L NO20044098A NO20044098A NO20044098L NO 20044098 L NO20044098 L NO 20044098L NO 20044098 A NO20044098 A NO 20044098A NO 20044098 A NO20044098 A NO 20044098A NO 20044098 L NO20044098 L NO 20044098L
Authority
NO
Norway
Prior art keywords
new connections
connections
new
Prior art date
Application number
NO20044098A
Other languages
English (en)
Norwegian (no)
Inventor
Xiao-Qing Lewell
Lee Andrew Harrison
Suzanne Elaine Keeling
Stephen Swanson
Rachael Anne Ancliff
Caroline Mary Cook
Colin David Eldred
Paul Martin Gore
Simon Tennby Hodgson
Duncan Bruce Judd
Graeme Michael Robertson
Martin Alistair Hayes
Gail Mills
Andrew John Walker
Mark Wilkinson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20044098L publication Critical patent/NO20044098L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20044098A 2002-03-28 2004-09-27 Nye forbindelser NO20044098L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0207449.0A GB0207449D0 (en) 2002-03-28 2002-03-28 Novel compounds
PCT/EP2003/003339 WO2003082291A1 (en) 2002-03-28 2003-03-27 N-{´ (2s) -4- (3, 4-difluorobenzyl) morpholin-2yl!methyl} -2-{3-' (methylsulphonyl) amino! phenyl}acetamide as ccr3 antagonist for the treatment of inflammatory conditions

Publications (1)

Publication Number Publication Date
NO20044098L true NO20044098L (no) 2004-10-04

Family

ID=9933998

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044098A NO20044098L (no) 2002-03-28 2004-09-27 Nye forbindelser

Country Status (22)

Country Link
US (1) US20060058299A1 (US07981874-20110719-C00313.png)
EP (1) EP1487453B1 (US07981874-20110719-C00313.png)
JP (1) JP4490110B2 (US07981874-20110719-C00313.png)
KR (1) KR20040095347A (US07981874-20110719-C00313.png)
CN (1) CN1642553A (US07981874-20110719-C00313.png)
AR (1) AR039177A1 (US07981874-20110719-C00313.png)
AT (1) ATE454892T1 (US07981874-20110719-C00313.png)
AU (1) AU2003216905A1 (US07981874-20110719-C00313.png)
BR (1) BR0308719A (US07981874-20110719-C00313.png)
CA (1) CA2479910A1 (US07981874-20110719-C00313.png)
DE (1) DE60330952D1 (US07981874-20110719-C00313.png)
ES (1) ES2339436T3 (US07981874-20110719-C00313.png)
GB (1) GB0207449D0 (US07981874-20110719-C00313.png)
IL (1) IL163648A0 (US07981874-20110719-C00313.png)
IS (1) IS7415A (US07981874-20110719-C00313.png)
MX (1) MXPA04009458A (US07981874-20110719-C00313.png)
NO (1) NO20044098L (US07981874-20110719-C00313.png)
PL (1) PL372930A1 (US07981874-20110719-C00313.png)
RU (1) RU2004126145A (US07981874-20110719-C00313.png)
TW (1) TW200400823A (US07981874-20110719-C00313.png)
WO (1) WO2003082291A1 (US07981874-20110719-C00313.png)
ZA (1) ZA200406990B (US07981874-20110719-C00313.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919356B2 (en) 2002-09-26 2005-07-19 Bristol Myers Squibb Company N-substituted heterocyclic amines as modulators of chemokine receptor activity
JP2009501792A (ja) * 2005-07-21 2009-01-22 アストラゼネカ・アクチエボラーグ ケモカイン受容体のモジュレーターとしてのｎ−ベンジル−モルホリン誘導体
HUP0500877A2 (en) * 2005-09-22 2007-05-29 Sanofi Aventis Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use and intermediates
HUP0500886A2 (en) * 2005-09-23 2007-05-29 Sanofi Aventis Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use
EP1931620A1 (en) * 2005-09-22 2008-06-18 Sanofi-Aventis Amino-alkyl-amide derivatives as ccr3 receptor liquids
HUP0800478A2 (en) * 2008-07-31 2010-03-01 Sanofi Aventis Substituted pyrrolidinyl-[1,3]thiazolo[4,5-b]pyridin derivatives as ccr3 receptor ligands
CN104203231A (zh) * 2011-12-01 2014-12-10 葛兰素集团有限公司 治疗和预防眼疾病的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS562929A (en) * 1979-06-21 1981-01-13 Sumitomo Chem Co Ltd Preparation of optically active cyclopentenolone
CZ284687B6 (cs) * 1986-04-30 1999-02-17 Dainippon Pharmaceutical Co., Ltd. Substituovaný benzamidový derivát, způsob jeho výroby a farmaceutický prostředek na jeho bázi
JPH01117882A (ja) * 1987-10-30 1989-05-10 Dainippon Pharmaceut Co Ltd 複素環式カルボン酸アミド誘導体
JPH03291274A (ja) * 1990-04-09 1991-12-20 Yoshitomi Pharmaceut Ind Ltd アミノアルキルモルホリン誘導体の製造法
JPH04270272A (ja) * 1991-02-25 1992-09-25 Yoshitomi Pharmaceut Ind Ltd アミノアルキルモルホリン誘導体の製造法
TW223629B (US07981874-20110719-C00313.png) * 1992-03-06 1994-05-11 Hoffmann La Roche
US5219856A (en) * 1992-04-06 1993-06-15 E. I. Du Pont De Nemours And Company Angiotensin-II receptor blocking, heterocycle substituted imidazoles
US6031097A (en) * 1997-10-27 2000-02-29 Neurogen Corporation 1-(N-(arylalkylaminoalkyl) aminoisoquinolines; a new class of dopamine receptor subtype specific ligands
AU2056800A (en) * 1998-12-18 2000-07-03 Du Pont Pharmaceuticals Company Heterocyclic piperidines as modulators of chemokine receptor activity
ATE254620T1 (de) * 1999-09-14 2003-12-15 Aventis Pharma Inc Unsubstituierte ethyl- und propylderivate von phenoxythienoisoxazolen als d4 antagonisten
PL362984A1 (en) * 2000-09-29 2004-11-15 Glaxo Group Limited Compounds useful in the treatment of inflammatory diseases
KR20030031198A (ko) * 2000-09-29 2003-04-18 글락소 그룹 리미티드 염증 질환 치료용 모르폴린-아세트아미드 유도체

Also Published As

Publication number Publication date
AU2003216905A1 (en) 2003-10-13
AR039177A1 (es) 2005-02-09
PL372930A1 (en) 2005-08-08
EP1487453B1 (en) 2010-01-13
JP2005525390A (ja) 2005-08-25
GB0207449D0 (en) 2002-05-08
DE60330952D1 (de) 2010-03-04
TW200400823A (en) 2004-01-16
ZA200406990B (en) 2005-11-08
MXPA04009458A (es) 2005-07-27
IL163648A0 (en) 2005-12-18
RU2004126145A (ru) 2005-06-27
CA2479910A1 (en) 2003-10-09
ATE454892T1 (de) 2010-01-15
CN1642553A (zh) 2005-07-20
ES2339436T3 (es) 2010-05-20
JP4490110B2 (ja) 2010-06-23
EP1487453A1 (en) 2004-12-22
WO2003082291A1 (en) 2003-10-09
BR0308719A (pt) 2005-01-04
KR20040095347A (ko) 2004-11-12
US20060058299A1 (en) 2006-03-16
IS7415A (is) 2004-08-19

Similar Documents

Publication Publication Date Title
NO20044588L (no) Nye forbindelser
NO20044432L (no) Nye forbindelser
NO20055219D0 (no) Nye forbindelser
NO20040014L (no) Nye forbindelser
NO20041003L (no) Nye forbindelser
NO20034665L (no) Nye forbindelser
NO20035428D0 (no) Nye anti-ineffektiver
NO20034992D0 (no) Nye 4-aninlinokinolin-3-karboksamider
NO20054224D0 (no) Nye 2-pyridinkarboksamidderivater
NO20044046L (no) Substituerte hydroksyetylaminer
NO20034970D0 (no) Nye arylheteroalkylaminderivater
DE50305301D1 (de) Einspritzventil
NO20040429L (no) Stromningsrorisolasjonssystem
NO20043595L (no) Nye kortikosteroider
NO20041185L (no) Nye sykloheksylsulfoner
ATE496887T1 (de) Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide
NO20054172D0 (no) Nye blandinger
NO20026285D0 (no) Nye peptider
NO20035248D0 (no) Nye fenylalkyloksy-fenyl derivater
DE60323585D1 (de) Seilzugeinstellseinrichtung
NO20022596D0 (no) Stikkpilleapplikator
NO20044098L (no) Nye forbindelser
NO20053511D0 (no) Nye fibrillin-liknende polypeptider
NO20025902L (no) Nye fenylpiperaziner
NO20055846D0 (no) Nye IL-8-liknende polypeptider

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application